This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Peragallo-Dittko, V. Search for Related Content PubMed PubMed Citation Articles by Peragallo-Dittko, V. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Clinical Trials Diabetes Social Bookmarking                         What's this?

Translating Clinical Trial Data Into New Patterns of Practice

From the Winthrop University Hospital, Diabetes Education Center, Mineola, New York

Correspondence to Virginia Peragallo-Dittko, RN, MA, BC-ADM, CDE, Winthrop University Hospital, Diabetes Education Center, 259 First Street, Mineola, NY, 11501 (vpdittko{at}winthrop.org).

Purpose

The ongoing research into the intricacies of glucoregulation and the upsurge in the number of pharmacologic therapies has broadened the treatment options for type 2 diabetes. Successful translation of pharmacologic clinical trial data into new patterns of practice begins by creating the space for a new therapy through a thorough understanding of its mechanism of action.

Conclusion

This article will discuss important considerations for identifying patients who could benefit from incretin mimetic therapy, the role of the diabetes educator in building a cohesive team, and teaching strategies that support patients' self-management efforts.

The Diabetes Educator, Vol. 35, No. Supplement 1, 18S-21S (2009)
DOI: 10.1177/0145721708330154


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?